Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/02/1996 | EP0734444A1 Gene encoding carboxypeptidase of aspergillus niger |
10/02/1996 | EP0734443A1 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis |
10/02/1996 | EP0734442A1 Diagnosis of metastatic cancer by the mts-1 gene |
10/02/1996 | EP0734441A1 Derivatives of tachyplesin having inhibitory activity towards plant pathogenic fungi |
10/02/1996 | EP0734440A1 Tumor cell fusions and methods for use of such tumor cell fusions |
10/02/1996 | EP0734439A1 p53-BINDING POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME |
10/02/1996 | EP0734438A1 Method for inducing dna synthesis in neurons |
10/02/1996 | EP0734436A1 Inhibition of dna methyltransferase |
10/02/1996 | EP0734397A1 Apparatus and method for polymer synthesis using arrays |
10/02/1996 | EP0734391A1 Pna-dna-pna chimeric macromolecules |
10/02/1996 | EP0734264A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
10/02/1996 | EP0734251A1 Method of transmitting a biologically active material to a cell |
10/02/1996 | EP0734201A1 Sepsis model |
10/02/1996 | EP0653943A4 Targeting somatic gene therapy to joints. |
10/02/1996 | EP0597850B1 Crystalline interleukin-4 |
10/02/1996 | EP0575497B1 Dna sequences which code for virulence characteristics of -$(streptococcus suis) and parts thereof, polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by -$(s. suis) in mammals, including man |
10/02/1996 | EP0502016B1 Novel vaccine |
10/02/1996 | EP0485578B1 Neurotropic growth factors comprising a homeobox peptide |
10/02/1996 | EP0458846B1 A thermostable (1,3-1,4)-beta-glucanase |
10/02/1996 | DE19512368A1 System zur Freisetzung und Isolierung von Nukleinsäuren System for releasing and isolating nucleic acids |
10/02/1996 | DE19512142A1 Infektiöser cDNA-Klon des Tick-Borne Enzephalitis (TBE)-Virus, davon abgeleiteter rekombinanter Impfstoff und Herstellung desselben sowie ein pharmazeutisches Produkt, das eine replizierbare Nukleinsäure enthält Infectious cDNA clone of the tick-borne encephalitis (TBE) virus derived therefrom recombinant vaccine and the preparation thereof and a pharmaceutical product containing a replicable nucleic acid |
10/02/1996 | CN1132529A DNA sequencing enzymes |
10/02/1996 | CN1132527A G-CSF analogue compsn. and its prepn. method |
10/02/1996 | CN1132516A Monoclonal IgA antibody against respiratory syncytial virus |
10/02/1996 | CN1132514A Protective antigens against parasites |
10/02/1996 | CN1132251A Pencillin V. Amidohydrrolase gene from fusarium oxysporum |
10/02/1996 | CN1132250A Structural method of anti-body albumen A-DNA probe |
10/02/1996 | CN1132247A Establishment and application of GP125 gene engineering strain containing EB virus shell albumen |
10/02/1996 | CN1132211A Process for purifying hepatitis B viral surface antigen comprising PRES2 peptide |
10/01/1996 | US5561236 Plant cell into which a gene has been introduced, the expression of which inhibits the antibiotic and herbicidal effects of bialaphos and phosphinothricin |
10/01/1996 | US5561224 Transcription factor for regulation of the development of skin and hair |
10/01/1996 | US5561223 DCC protein |
10/01/1996 | US5561064 Production of pharmaceutical-grade plasmid DNA |
10/01/1996 | US5561063 Recombinant human cytomegalovirus containing foreign gene |
10/01/1996 | US5561058 Methods for coupled high temperatures reverse transcription and polymerase chain reactions |
10/01/1996 | US5561053 Dna molecule containing transcriptional regulatory regions, for genetic engineering |
10/01/1996 | US5561044 Detection of mycobacteria by multiplex strand displacement nucleic acid amplification |
10/01/1996 | US5561043 Genetic engineering |
10/01/1996 | US5560929 Structured copolymers and their use as absorbents, gels and carriers of metal ions |
10/01/1996 | CA2172659A1 Fungal cell wall protein cly4 |
10/01/1996 | CA2172305A1 Multiple antigenic peptide comprising at least two hepatitis c virus-associated peptides |
10/01/1996 | CA1338620C Regulation of gene expression |
09/26/1996 | WO1996029605A2 Compounds and methods for the dectection of t. cruzi infection |
09/26/1996 | WO1996029604A1 Method for diagnosing a patient for chlamydia |
09/26/1996 | WO1996029431A2 Dna diagnostics based on mass spectrometry |
09/26/1996 | WO1996029429A1 System to detect protein-rna interactions |
09/26/1996 | WO1996029423A1 Compositions and methods for inducing infection by retroviral vectors outside of their host range |
09/26/1996 | WO1996029422A1 Nucleic acid carrier |
09/26/1996 | WO1996029421A1 Vectors for gene delivery |
09/26/1996 | WO1996029420A1 Plants resistant to tospoviruses |
09/26/1996 | WO1996029419A1 Transformed embryogenic microspores for the generation of fertile homozygous plants |
09/26/1996 | WO1996029418A1 Introduction of dna into bacillus strains by conjugation |
09/26/1996 | WO1996029417A1 Il-13 receptor specific chimeric proteins and uses thereof |
09/26/1996 | WO1996029416A1 Aspergillus arabinofuranosidase |
09/26/1996 | WO1996029415A1 Endo beta-1,4-glucanase from aspergillus |
09/26/1996 | WO1996029414A1 Identification and cloning of a mobile transposon from aspergillus |
09/26/1996 | WO1996029413A2 Dna encoding human papilloma virus type 18 |
09/26/1996 | WO1996029412A1 Proteinase k resistant surface protein of neisseria meningitidis |
09/26/1996 | WO1996029411A1 Protein production and delivery |
09/26/1996 | WO1996029410A1 In vivo generation of antibodies against antigens secreted in a host by transfected mel cells |
09/26/1996 | WO1996029409A2 Rage tumor rejection antigens |
09/26/1996 | WO1996029408A1 Il-17 receptor |
09/26/1996 | WO1996029407A2 Cellubrevin homologs |
09/26/1996 | WO1996029406A2 Nuclear localization factor associated with circadian rhythms |
09/26/1996 | WO1996029405A2 MODULATORS OF ob GENE AND SCREENING METHODS THEREFOR |
09/26/1996 | WO1996029404A1 HUMAN METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE mGluR6 |
09/26/1996 | WO1996029403A1 Bcl2 derived genetic elements associated with sensitivity to chemotherapeutic drugs |
09/26/1996 | WO1996029402A1 Tumor marker protein for cancer risk assessment |
09/26/1996 | WO1996029401A1 Human b-cell translocation genes-2 and 3 |
09/26/1996 | WO1996029400A1 Method for regulating the expression of a gene in a baculovirus using a retinoic acid receptor binding site, and vector therefor |
09/26/1996 | WO1996029399A1 Antisense oligonucleotides for inhibiting helicobacter pylori activity |
09/26/1996 | WO1996029398A1 Delivery and expression of heterologous genes using upstream enhancer regions of mammalian gene promoters |
09/26/1996 | WO1996029397A1 Novel endoglucanases |
09/26/1996 | WO1996029396A1 Recombinant infectious laryngotracheitis virus and uses thereof |
09/26/1996 | WO1996029395A1 Cell culture method |
09/26/1996 | WO1996029393A1 Recombinant human immunodeficiency virus-producing cell |
09/26/1996 | WO1996029391A1 Host cell expressing reduced levels of a metalloprotease and methods using the host cell in protein production |
09/26/1996 | WO1996029344A1 Insulin derivatives |
09/26/1996 | WO1996029341A1 Human stat4 |
09/26/1996 | WO1996029338A1 Identification of gene mutations associated with congenital lipoid adrenal hyperplasia |
09/26/1996 | WO1996029337A1 Thiono triester modified antisense oligodeoxynucleotide phosphorothioates |
09/26/1996 | WO1996029097A1 Stem-loop and circular oligonucleotides |
09/26/1996 | WO1996029096A1 Gene transfer preparation |
09/26/1996 | WO1996029091A1 Treatment of papillomavirus-associated lesions using interleukin-12 |
09/26/1996 | WO1996028967A1 Transgenic non-primatal mammals wherein serotypes of higher primates have been expressed by foreign gene transfer and method of creating the same |
09/26/1996 | WO1996028966A1 Transformant of nonprimatial mammal having serotype of advanced primate expressed by foreign gene transduction and process for producing the same |
09/26/1996 | WO1996024686A3 Detection of bacteria of genus listeria using nucleic probe hybridisation techniques |
09/26/1996 | WO1996023079A3 Method for suppressing dna fragment amplification during pcr |
09/26/1996 | WO1996023071A3 MONOCLONAL ANTIBODIES SPECIFIC FOR DIFFERENT EPITOPES OF HUMAN gp39 AND METHODS FOR THEIR USE IN DIAGNOSIS AND THERAPY |
09/26/1996 | WO1996023070A3 HUMAN RETINOID X RECEPTOR - GAMMA (hRXR-GAMMA) |
09/26/1996 | WO1996023065A3 Inhibition of neovascularization using vegf-specific oligonucleotides |
09/26/1996 | WO1996021014A3 Production and administration of high titer recombinant retroviruses |
09/26/1996 | WO1996017924A3 Novel hedgehog-derived polypeptides |
09/26/1996 | WO1996011272A3 Papilloma virus-like particles, fusion proteins and process for producing the same |
09/26/1996 | CA2216597A1 Method for regulating the expression of a gene in a baculovirus using a retinoic acid receptor binding site, and vector therefor |
09/26/1996 | CA2216284A1 Thiono triester modified antisense oligodeoxynucleotide phosphorothioates |
09/26/1996 | CA2216147A1 Cellubrevin homologs |
09/26/1996 | CA2216139A1 Recombinant infectious laryngotracheitis virus and uses thereof |
09/26/1996 | CA2215730A1 Human metabotropic glutamate receptor subtype mglur6 |
09/26/1996 | CA2215694A1 Insulin derivatives |